Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Clinical Trials Arena
Fri, 06/6/25 - 12:03 pm
Avenzo Therapeutics
AVZO-023
breast cancer
clinical trials
Valneva reports data from Phase II chikungunya vaccine trial in children
Clinical Trials Arena
Fri, 06/6/25 - 11:55 am
Valneva
VLA1553-221
chikungunya virus
vaccines
clinical trials
CEPI
Ixchiq
Otsuka's kidney disease drug halves UPCR levels in phase 3 study
Fierce Biotech
Fri, 06/6/25 - 11:47 am
Otsuka
kidney disease
clinical trials
sibeprenlimab
Corcept unveils promising survival data from failed phase 2 ALS trial
Fierce Biotech
Thu, 06/5/25 - 09:59 am
Corcept Therapeutics
ALS
clinical trials
dazucorilant
Ascletis’s daily acne tablet set for China review after Phase III win
Clinical Trials Arena
Thu, 06/5/25 - 09:49 am
Ascletis
China
clinical trials
denifanstat
acne
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
Benzinga
Wed, 06/4/25 - 10:38 pm
AnaptysBio
clinical trials
rheumatoid arthritis
rosnilimab
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
CNBC
Wed, 06/4/25 - 11:22 am
Moderna Therapeutics
vaccines
clinical trials
placebo
COVID-19
Robert F Kennedy Jr.
Vigil's rare brain disease drug flunks phase 2 study, but Sanofi takeover is unaffected
Fierce Biotech
Wed, 06/4/25 - 11:06 am
Vigil Neuroscience
Sanofi
M&A
clinical trials
iluzanebart
ASCO25: Imunon shares positive results from trial of IMNN-001 for ovarian cancer
Clinical Trials Arena
Wed, 06/4/25 - 09:45 am
ASCO 2025
Imunon
IMNN-001
ovarian cancer
clinical trials
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
Clinical Trials Arena
Tue, 06/3/25 - 11:34 am
Arrowhead Pharmaceuticals
clinical trials
ARO-ALK7
RNAi
obesity
ASCO: OSE shares 65% overall survival rate behind therapeutic cancer vaccine's phase 2 win
Fierce Biotech
Tue, 06/3/25 - 11:14 am
ASCO 2025
OSE Immunotherapeutics
vaccines
pancreatic cancer
clinical trials
Tedopi
Regeneron's weight-loss drug combo helps preserve muscle in study
MSN/Reuters
Tue, 06/3/25 - 10:43 am
Regeneron
Novo Nordisk
Wegovy
trevogrumab
obesity
clinical trials
Lyra Therapeutics stock soars on positive Phase 3 trial results
Investing.com
Mon, 06/2/25 - 11:41 pm
Lyra Therapeutics
clinical trials
chronic rhinosinusitis
LYR-210
Kymera, with new data, takes early step toward a Dupixent-like pill
BioPharma Dive
Mon, 06/2/25 - 11:33 pm
Kymera
autoimmune diseases
clinical trials
Dupixent
protein degradation
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
Yahoo/Reuters
Mon, 06/2/25 - 11:29 am
Novartis
radiotherapy
Pluvicto
prostate cancer
clinical trials
ASCO: AstraZeneca's oral SERD tied to 56% PFS benefit in phase 3 breast cancer trial
Fierce Biotech
Mon, 06/2/25 - 11:26 am
AstraZeneca
ASCO 2025
Camizestrant
clinical trials
breast cancer
Vera drug scores in closely watched study in rare kidney disease
BioPharma Dive
Mon, 06/2/25 - 11:11 am
Vera Therapeutics
IgA nephropathy
clinical trials
atacicept
ASCO25: Johnson & Johnson reports data from Phase I trial of prostate cancer drug
Clinical Trials Arena
Mon, 06/2/25 - 11:09 am
JNJ
clinical trials
ASCO 2025
pasritamig
bispecific antibodies
metastatic castration-resistant prostate cancer
Summit’s bispecific misses survival endpoint in global phase III trial but analysts remain optimistic
BioSpace
Fri, 05/30/25 - 11:46 am
Summit Therapeutics
ivonescimab
PD-1xVEGF
clinical trials
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Fierce Biotech
Fri, 05/30/25 - 11:29 am
Roche
fenebrutinib
Btk inhibitors
MS
clinical trials
multiple sclerosis
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »